China orders recall of Glaxo drug

China ordered British pharma­ceutical giant GlaxoSmithKline to recall an antibiotic used to treat infections in children which was found to be tainted with a plasticiser. Traces of diisodecyl phthalate, which is used to make plastics more flexible,...

China ordered British pharma­ceutical giant GlaxoSmithKline to recall an antibiotic used to treat infections in children which was found to be tainted with a plasticiser. Traces of diisodecyl phthalate, which is used to make plastics more flexible, were found in Glaxo’s amoxicillin and clavulanate potassium suspension, which is sold under the tradename Augmentin, the State Food and Drug Administration said on its website.

Glaxo was ordered to immediately stop selling the antibiotic and recall those which had already entered the market. Hong Kong last week ordered a recall of Augmentin after tests revealed the antibiotic syrup produced by Glaxo’s French factory contained an unsafe level of DIDP.

Sign up to our free newsletters

Get the best updates straight to your inbox:

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.